IGF2: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It's the GeneMedi's summary page for Target/Biomarker Introduction of IGF2. The page also collects GeneMedi's different modalities and formats products for IGF2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the IGF2 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Secreted Protein/Potential Cytokines.
This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
Target ID | GM-T90572 |
Target Name | IGF2 |
Gene ID | 3481,16002,24483,710802,483664,101093644,281240,100034182 |
Gene Symbol and Synonyms | C11orf43,GRDF,Igf-2,IGF-II,IGF2,IGFII,M6pr,Mpr,Peg2,PP9974,RNIGF2,SRS3 |
Uniprot Accession | P01344,P01346,P07456,P51459 |
Uniprot Entry Name | IGF2_HUMAN,IGF2_RAT,IGF2_BOVIN,IGF2_HORSE |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, INN Index, Cytokine Target |
Disease | Ovary Cancer |
Gene Ensembl | ENSG00000167244 |
Target Classification | N/A |
Pre-made IGF2-specific INN-index biosimilar (antibody&conjugates)
Anti-IGF2 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Detail |
GMP-Bios-ab-634 | Pre-Made Xentuzumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody | Xentuzumab | IGF1;IGF2 | Whole mAb | Detail | |
GMP-Bios-ab-160 | Pre-Made Dusigitumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody | Dusigitumab | IGF1;IGF2 | Whole mAb | Detail |
Click to check more INN-indexed antibody & protein biosimilar
Pre-made anti-IGF2 inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark antibody for drug discovery and mechanism of action (MOA) research
Pre-made anti-IGF2 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-IGF2 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Antibody Name | Species | Format | Classified by tag | Detail |
Anti-IGF2 monoclonal antibody | Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
Recombinant multi-species IGF2/ C11orf43/ GRDF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IGF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Products Name | Species | Expression Platform | Detail |
IGF2 protein | Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine | Mammalian cell | Detail |
Cytokine Products for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces human, Cynomolgus/ Rhesus macaque, rat, mouse insulin-like growth factor 2 (IGF2) His+Avi (Biotinylated) for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Insulin-like growth factor 2 (IGF-2) is one of three protein hormones that share structural similarity to insulin. The MeSH definition reads: "A well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on somatotropin. It is believed to be a major fetal growth factor in contrast to Insulin-like growth factor 1, which is a major growth factor in adults.
Target | Species | Antigen Product Name | Bioactivity validation of Antigen | Antibody Product Name | Bioactivity validation of Antibodies | Detail |
IGF2 | Human, Cynomolgus/Rhesus macaque, rat, mouse | insulin-like growth factor 2 (IGF2) protein | Affintiy&bioactivity validated by ELISA, cell culture validated | Anti-IGF2 monoclonal antibody | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). | Detail |
Click to check more Cytokine Products
Pre-made IGF2 viral vector in GM Promise-ORFTM
Cat No. | Products name | NM ID | Species | Type | Detail |
vGMLV000393 | human IGF2 Lentivirus particle | NM_001127598.2 | Human | Lentivirus particle | Detail |
pGMLV000475 | human IGF2 Lentivirus plasmid | NM_001127598.2 | Human | Lentivirus plasmid | Detail |
pGMLV000393 | human IGF2 Lentivirus plasmid | NM_001127598.2 | Human | Lentivirus plasmid | Detail |
pGMAP000466 | Human IGF2 Adenovirus plasmid | BC000531 | Human | Adenovirus plasmid | Detail |
vGMLV000475 | human IGF2 Lentivirus particle | NM_001127598.2 | Human | Lentivirus particle | Detail |
vGMAP000466 | Human IGF2 Adenovirus particle | BC000531 | Human | Adenovirus particle | Detail |
pGMLV000050 | rat Igf2 Lentivirus plasmid | NM_031511 | Rat | Lentivirus plasmid | Detail |
pGMAD000117 | mouse Igf2 Adenovirus plasmid | NM_001315489.1 | Mouse | Adenovirus plasmid | Detail |
pGMAAV000051 | mouse Igf2 AAV plasmid | NM_010514.3 | Mouse | AAV plasmid | Detail |
pGMAAV000327 | house mouse Igf2 AAV plasmid | NM_001315489.1 | House Mouse | AAV plasmid | Detail |
vGMLV000050 | rat Igf2 Lentivirus particle | NM_031511 | Rat | Lentivirus particle | Detail |
vGMAD000117 | mouse Igf2 Adenovirus particle | NM_001315489.1 | Mouse | Adenovirus particle | Detail |
vGMAAV000051 | mouse Igf2 AAV particle | NM_010514.3 | Mouse | AAV particle | Detail |
vGMAAV000327 | house mouse Igf2 AAV particle | NM_001315489.1 | House Mouse | AAV particle | Detail |
About Promise-ORFTM:
Discover the largest collection of ORF/cDNA expression clones from different species, including human, mouse, rat, and more with GeneMedi's Promise-ORFTM. Our collection of ORFs expression clones come in verified mammalian or viral vectors lentivirus, AAV, and adenovirus) and our Promise-ORFTM viral-ready expression vectors make it easy for you to improve viral vector packaging efficiency or directly transfect mammalian cells, resulting in stronger and easier expression detection. Click to search your GOI
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.